好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Oral Fingolimod (FTY720) Reduces Inflammatory Activity vs Placebo in Relapsing-Remitting Multiple Sclerosis: 24-Month MRI Results from a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Study (FREEDOMS)
MS and Related Diseases
(-)
005
Authors/Disclosures
Ernst-Wilhelm Radue, MD (Medical Image Analysis Center) Dr. Radue has nothing to disclose.
Paul W. O'Connor, MD No disclosure on file
Chris H. Polman, MD (MS Center, VU Medical Center) No disclosure on file
Reinhard Hohlfeld, MD (Neurologic Klinik & Inst for Clinic Neuroimmun) Dr. Hohlfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Peter A. Calabresi, MD, FAAN (Johns Hopkins University) Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Danielle M. Andrade, MD (University of Toronto) Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zodiac. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke therapeutics. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities.
No disclosure on file
Katherine Agoropoulou, PhD No disclosure on file
Lixin Zhang-Auberson, MD, PhD (H. Lundbeck A/S) No disclosure on file
No disclosure on file
Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) Dr. Kappos has nothing to disclose.